Evidence quality 4.38/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 3/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 4/5
- D6 Prose
- 4/5
- D7 Perception honesty
- 5/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Glyphosate is the most-used herbicide in world agriculture and the active ingredient in Roundup. The IARC 2015 reclassification of glyphosate as "probably carcinogenic to humans" (Group 2A), the multi-billion-dollar Monsanto/Bayer verdict against the company in Johnson v. Monsanto (2018), and a steady stream of "Roundup found in your cereal" press cycles have cemented public concern. Many consumers treat any detectable glyphosate residue on oats, wheat or chickpeas as a meaningful cancer risk and purchase organic specifically to avoid it. Surveys consistently rank pesticides among the top food-safety concerns of US adults.
Rough estimate: 46% of US adults rank pesticides as a top-3 food safety concern (IFIC 2025)
Actual
~99.9% of US dietary intake estimates fall below 1/1000 of EFSA's 0.5 mg/kg/day acceptable daily intake; no statistically significant cancer association in the largest applicator cohort
US adults consuming conventional produce, grains and processed foods
Show derivation
The US adult lifetime dietary cancer attributable to glyphosate is set as a conservative 1-in-1,000,000 placeholder, the same floor used by `pesticide-residue-food`, because no dietary-exposure cohort has detected a cancer signal and applicator-cohort evidence (Andreotti et al. 2018, JNCI, N=54,251 -- the largest prospective study available) reports no association between glyphosate use and non-Hodgkin lymphoma (rate ratio 0.87, 95% CI 0.64-1.20 for highest exposure quartile vs never users, p-trend 0.95). Typical US dietary intake estimates from the FDA Total Diet Study are roughly 1/1000 of EFSA's acceptable daily intake of 0.5 mg/kg/day. The IARC 2015 Group 2A classification (Monograph 112) rested on "limited" human evidence from occupational case-control studies and "sufficient" evidence in laboratory rodents; EPA (2020 interim review), EFSA (2023 peer review), ECHA (2022 RAC opinion), Health Canada (2017 re-evaluation), and Australian APVMA have each concluded that glyphosate is not likely to be carcinogenic to humans at expected exposure levels. The 1-in-1,000,000 figure is a conservative ceiling acknowledging the IARC dissent and possible low-dose effects not yet measurable; the true dietary figure may be effectively zero. The wide uncertainty band reflects this institutional disagreement, not measured variability.
Caveats: This entry addresses dietary glyphosate exposure for a US adult consuming conven…
This entry addresses dietary glyphosate exposure for a US adult consuming conventional produce, grains and processed food, and its plausible attributable cancer risk. It does not cover occupational applicator exposure beyond the multiplier above, ecological effects (pollinators, amphibians, aquatic invertebrates), herbicide-resistance evolution in weed populations, or non-cancer endpoints (kidney function, endocrine effects, microbiome) which remain active research areas without population-scale consensus. The 1-in-1,000,000 figure is a conservative ceiling, not a measured rate -- no dietary-exposure cohort has detected a cancer signal at typical consumer exposures, and the largest applicator cohort (Andreotti 2018, N=54,251) reports null at all exposure quartiles. The IARC Group 2A vs EPA/EFSA/ECHA/Health Canada non- carcinogen split is real and load-bearing; this entry sides with the larger-cohort-weighted regulatory consensus for the dietary scope while flagging the IARC dissent in the assumptions. Zhang et al. 2019 meta- analysis (a frequently cited counterpoint) is methodologically controversial because of its high-exposure-only subgroup focus and was not used to derive a lifetime number here; the literature on its conclusions remains genuinely split. If long-term US dietary cohort data eventually report a signal, this entry will be revised.
How the risk varies
The headline figure averages across very different situations. Here’s how the probability varies by scenario or context:
1 in 1,000,000
intake typically ~1/1000 of EFSA ADI; placeholder floor based on null applicator-cohort finding extrapolated downward by orders of magnitude
1 in 2,000,000
modestly lower glyphosate residue exposure than US estimates; EFSA dietary risk assessment found no consumer concern at approved-use levels
1 in 40 · 2.5%
baseline lifetime NHL risk ~2.14%; Andreotti 2018 found RR 0.87 (not statistically elevated) for highest glyphosate exposure quartile -- so the applicator subgroup tracks the baseline rate rather than dramatically exceeding it; scope is occupational, not dietary
Bar length and shade rank these scenarios against each other, not against other risks. The exact odds are shown beside each.
Related risks
Other risks on similar themes — for exploring related fears.
Pesticide residue
What are the odds that pesticide residue on conventional produce will harm your health?
Acrylamide & cancer
How much does dietary acrylamide from fried or baked starchy foods actually raise cancer risk?
Charred meat & cancer
How much does eating charred or well-done grilled meat actually raise your cancer risk?
Low-fiber CRC risk
What are the odds of getting colorectal cancer from not eating enough fiber?
Red meat & CRC
How much does eating red or processed meat every day actually raise your colorectal cancer risk?
Pick challenger
Glyphosate is one of the rare cases in this catalogue where major institutions explicitly disagree on the hazard, and the public conversation has settled on the more alarming of the two readings. IARC’s 2015 Monograph 112 classified the herbicide as Group 2A — “probably carcinogenic to humans” — on the basis of limited human evidence for non-Hodgkin lymphoma and sufficient evidence in laboratory animals. EPA’s 2020 interim review, ECHA’s 2022 RAC opinion, EFSA’s 2023 peer review and Health Canada’s 2017 re-evaluation each conclude that glyphosate is not likely to be carcinogenic to humans at expected exposures, drawing on a larger set of carcinogenicity studies including industry-submitted dossiers that IARC excluded. The split is genuine; it is not a story of “industry vs science”.
For dietary exposure — the question most consumers actually face — the
strongest negative evidence comes from the Agricultural Health Study.
Andreotti et al. (JNCI, 2018) followed 54,251 licensed pesticide applicators
prospectively and reported no association between glyphosate use and non-
Hodgkin lymphoma at any exposure quartile (rate ratio 0.87, 95% CI 0.64-
1.20 for highest vs never users). Applicators have exposures orders of
magnitude above any dietary consumer. A null at that end of the exposure
distribution implies that the consumer dietary signal, if any, sits well
below the detection floor of population epidemiology. Typical US dietary
intake estimates from the FDA Total Diet Study are roughly one-thousandth
of EFSA’s acceptable daily intake. The 1-in-1,000,000 placeholder used here
mirrors pesticide-residue-food and is a conservative ceiling — the true
dietary figure may be effectively zero.
The headline does not apply uniformly. Occupational licensed applicators
face genuinely higher exposure, and although Andreotti 2018 reports no
significantly elevated cancer rate even at the high quartile, the IARC
dissent and a nominally elevated (non-significant) acute-myeloid-leukemia
signal in the heaviest-exposed applicators keep the question live for that
subgroup. Hobby gardeners using glyphosate sprays heavily without
protective equipment sit between consumer and applicator scope (see
gardening-without-ppe). Heavy consumption of US wheat, oat or pulse
products tracks the highest residues in the food supply, driven by pre-
harvest desiccation practices, but even the upper end of intake remains
far below regulatory acceptable daily intake levels. Choosing organic
substitutes reduces an already very low dietary exposure further; the
absolute risk difference at consumer scope is small.
Related tidbits
46% of US adults rank pesticides among their top food-safety concerns, yet dietary glyphosate cancer risk sits at roughly 1 in 1,000,000 or less. Nearly all measured intake falls far below the acceptable daily limit.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
4/4 sources independently verified verbatim against the cited source
-
[1] International Agency for Research on Cancer (IARC), WHO — IARC News: Q&A on Glyphosate Verified
IARC News: Q&A on Glyphosate- Statistic
IARC Monograph Volume 112 (March 2015) classified glyphosate as Group 2A, "probably carcinogenic to humans", based on limited evidence in humans for non-Hodgkin lymphoma and sufficient evidence in laboratory animals.- Excerpt
“Glyphosate was classified as "probably carcinogenic to humans" (Group 2A) based on "limited" evidence of cancer in humans from real-world exposures that actually occurred, "sufficient" evidence of cancer in experimental animals from studies of pure glyphosate, and "strong" evidence for genotoxicity, both for pure glyphosate and for glyphosate formulations. ”
- Source data from
- 2016-03-01
- Accessed
- 2026-05-30 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- The IARC Group 2A classification is a hazard-identification, not a risk-quantification. It states that the agent has the potential to cause cancer under some exposure conditions, not that any particular exposure level produces a measurable cancer rate. The dietary cancer probability for a typical consumer is not computable from this source alone. Cited here to anchor the IARC half of the institutional split and to ensure the entry is honest about the strongest evidence in the "concerning" direction.
- Independence
- IARC's evaluation drew on ~1,000 publicly available studies via an independent working group with conflict-of-interest screening. The working-group methodology is institutionally distinct from EPA, EFSA and ECHA cancer-classification processes, which weight the evidence base differently (notably by including registrant-submitted studies not always in IARC's review universe).
-
[2] US Environmental Protection Agency — Glyphosate (Ingredient Used in Pesticide Products) Verified
Glyphosate (Ingredient Used in Pesticide Products)- Statistic
EPA Interim Registration Review (2020) concluded that glyphosate is not likely to be carcinogenic to humans at exposure levels expected from approved uses; review covered 15 acceptable carcinogenicity studies, more than IARC's 8 animal studies.- Excerpt
“"EPA concluded that glyphosate is not likely to be carcinogenic to humans." EPA further notes that its position is based on "a more extensive dataset of studies" than IARC reviewed. ”
- Source data from
- 2022-08-01
- Accessed
- 2026-05-30 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- EPA's Interim Registration Review for glyphosate (2020) and subsequent defenses of that decision form the institutional counterweight to IARC. Like IARC the conclusion is hazard-level rather than a quantitative cancer rate, but the framing -- "not likely carcinogenic to humans" at expected exposures -- bears directly on the dietary consumer scope this entry concerns. Used jointly with EFSA below to establish that the regulatory consensus across the largest assessment bodies is non-carcinogenic at dietary levels.
- Independence
- EPA's review universe includes registrant-submitted carcinogenicity studies that IARC excluded; EPA and IARC analysed substantially overlapping but not identical study sets. EFSA's evaluation is institutionally separate and reaches a similar conclusion via a separate review pipeline.
-
[3] European Food Safety Authority (EFSA) — Glyphosate: No Critical Areas of Concern; Data Gaps Identified Verified
Glyphosate: No Critical Areas of Concern; Data Gaps Identified- Statistic
EFSA July 2023 peer review concluded no critical areas of concern for human, animal or environmental health from glyphosate; relied on ECHA RAC 2022 opinion that glyphosate does not meet criteria for classification as carcinogenic, mutagenic or reprotoxic.- Excerpt
“EFSA's peer review concluded there were "no critical areas of concern" regarding glyphosate's impact on human health, animal welfare, or environmental safety. EFSA relied on ECHA's classification finding that glyphosate "did not meet the scientific criteria to be classified as a carcinogenic, mutagenic or reprotoxic substance." ”
- Source data from
- 2023-07-06
- Accessed
- 2026-05-30 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- EFSA's 2023 conclusion is the third major regulatory data point against IARC's Group 2A classification (after EPA 2020 and ECHA 2022 RAC). It does not produce a dietary cancer probability either, but strengthens the case that across the major Western regulators the consensus on the dietary-consumer cancer question converges on "no measurable increase". Combined with Andreotti below, this is the basis for the 1-in-1,000,000 conservative placeholder rather than a higher figure.
- Independence
- EFSA's peer review draws on ECHA's hazard classification and on member-state rapporteur assessments. Methodologically independent of both EPA (different review pipeline, different study weighting) and IARC (different evaluation rules; EFSA reviews regulatory dossiers including industry submissions, IARC focuses on publicly available studies).
-
[4] Journal of the National Cancer Institute (Andreotti et al.) — Glyphosate Use and Cancer Incidence in the Agricultural Health Study Verified
Glyphosate Use and Cancer Incidence in the Agricultural Health Study- Statistic
Prospective US cohort, N=54,251 licensed pesticide applicators (44,932 glyphosate users; 7,290 incident cancers diagnosed during follow-up). No association between glyphosate use and non-Hodgkin lymphoma overall or any NHL subtype (rate ratio 0.87, 95% CI 0.64-1.20 for highest exposure quartile vs never users, p-trend 0.95).- Excerpt
“"In this large, prospective cohort study, no association was apparent between glyphosate and any solid tumors or lymphoid malignancies overall, including NHL and its subtypes." ”
- Source data from
- 2018-02-08
- Accessed
- 2026-05-30 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- The Agricultural Health Study is the largest prospective cohort of licensed applicators with quantitative glyphosate-exposure data. It addresses the cancer hypothesis most prominently raised by IARC (non-Hodgkin lymphoma) and reports no association at any exposure quartile. A nominally elevated acute-myeloid-leukemia signal in the highest exposure quartile (rate ratio 2.44, 95% CI 0.94-6.32) is the one residual finding worth flagging and is not statistically significant. This is the strongest single piece of dietary-relevant negative evidence: applicators have orders-of-magnitude higher exposure than dietary consumers, and the null at the high end implies a very small ceiling on consumer-level dietary harm.
- Independence
- The Agricultural Health Study is a long-running NCI/NIEHS/EPA collaboration tracking ~89,000 farmers and spouses; independent of IARC, EPA classification reviews and EFSA peer reviews. The Andreotti 2018 update extended follow-up by ~12 years relative to the 2005 analysis that contributed to IARC's evaluation.